Skip to search formSkip to main contentSkip to account menu

liblomycin

Known as: N(1)-(3-((3-(bis((3,4-bis(phenylmethoxy)phenyl)methyl)amino)propyl)methylamino)propyl)bleomycinamide, libromycin 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Bleomycin

Narrower (1)

NK 313
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1992
Review
1992
Bleomycin pulmonary toxicity: current status and future directions.
Bleomycin is a polypeptide antibiotic that has been used in clinical cancer chemotherapy for over 20 years. Risk factors… 
1991
1991
Interaction of hyperthermia with bleomycin and liblomycin: effects on CHO cells in vitro.
The relative ability of hyperthermia to potentiate the cytotoxicity of bleomycin A2 (BLM) and the lipophilic bleomycin analog… 
1990
1990
Synergistic Effect in Culture of Bleomycin‐group Antibiotics and N‐Solanesyl‐N, N’‐bis(3,4‐dimethoxybenzyl)ethylenediamine, a Synthetic Isoprenoid
Like bleomycin and peplomycin, libromycin, a newly developed bleomycin‐group antibiotic, was potentiated 130‐fold against Chinese… 
1990
1990
Liblomycin-mediated DNA cleavage in human head and neck squamous carcinoma cells and purified DNA.
Liblomycin (LBM), a novel bleomycin analogue, and bleomycin A2 (BLM A2) were compared with respect to their relative potential to… 
Highly Cited
1989
Highly Cited
1989
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
A new model to predict antitumor activity of new analogues was developed, and the cross-resistance against cisplatin (CDDP) and… 
1989
1989
Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
Three bleomycin (BLM)-resistant sublines were isolated from a human head and neck squamous cell carcinoma cell line (A-253… 
1989
1989
In vitro activity of bleomycin, tallysomycin S10b, and liblomycin against fresh human tumor cells.
The objective of this study was to compare the relative in vitro cytotoxicity of bleomycin to that of two newer-generation… 
1988
1988
DNA cleavage activity of liblomycin (NK313), a novel analog of bleomycin.
Liblomycin (NK313), a novel analog of bleomycin and peplomycin (PEP), produced acid soluble DNA, base propenals and nucleo bases… 
1987
1987
Peplomycin and liblomycin, a new analogues of bleomycin.
  • T. TakitaT. Ogino
  • Biomedicine & pharmacotherapy = Biomedecine…
  • 1987
  • Corpus ID: 12841991
Peplomycin, derivative of Bleomycin which was developed because of a lower pulmonary toxicity and broader anti-tumor spectrum in… 
1987
1987
Liblomycin, a new analogue of bleomycin.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)